4Ts Score for Heparin-Induced Thrombocytopenia
Differentiates patients with HIT from those with other causes of thrombocytopenia.
114 entries · Page 1 of 4
Differentiates patients with HIT from those with other causes of thrombocytopenia.
Predicts need for massive transfusion in trauma patients.
Assesses number of lymphocytes and predicts CD4 count.
Frequently used to assess neutropenic fever in chemotherapy patients.
Predicts likelihood of breast cancer with sentinel lymph node metastasis has also spread to additional lymph nodes.
Predicts survival in HCC patients.
Predicts risk of progression of asymptomatic (smoldering) multiple myeloma to active myeloma or amyloidosis.
Determines progression of disease and proper treatment course for patients with HCC.
Stages chronic lymphocytic leukemia, similar to Rai Staging System .
Calculates total blood volume, red blood cell volume, and plasma volume.
Calculates body mass index and body surface area.
Calculates rate of distant brain failure after stereotactic radiosurgery for brain metastasis.
Calculates a corrected calcium level for patients with hypoalbuminemia or hyperalbuminemia.
Predicts 10-year survival in patients with multiple comorbidities.
Identifies febrile neutropenia patients at low risk of serious complications.
Assesses adequacy of response to platelet transfusion.
Evaluates bone marrow response to anemia, often in sickle cell patients.
Calculates CrCl according to the Cockcroft-Gault equation.
Estimates volume of cryoprecipitate recommended for fibrinogen replacement.
Assesses severity of CRS in patients on immunotherapy.
Assesses 5 year risk of treatment failure based on clinical factors.
Predicts likelihood of recurrence of first VTE.
Estimates survival in patients with primary myelofibrosis.
Estimates volume of whole blood to process by apheresis to yield an appropriate DLI dosage.
Predicts 3 month outcome in ischemic stroke patients receiving TPA.
Determines ability of patient to tolerate therapies in serious illness, specifically for chemotherapy, simpler than the Karnofsky Scale .
Predicts outcomes after CML treatments, specifically adjusted for tyrosine kinase treatments.
No entries match your filter.